Log in to save to my catalogue

Bevacizumab beyond first disease progression in metastatic colorectal cancer: a review of recent cli...

Bevacizumab beyond first disease progression in metastatic colorectal cancer: a review of recent cli...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracacademiconefile_A409374858

Bevacizumab beyond first disease progression in metastatic colorectal cancer: a review of recent clinical trial data

About this item

Full title

Bevacizumab beyond first disease progression in metastatic colorectal cancer: a review of recent clinical trial data

Publisher

Future Medicine Ltd

Journal title

Colorectal cancer, 2015-02, Vol.4 (1), p.13-25

Language

English

Formats

Publication information

Publisher

Future Medicine Ltd

More information

Scope and Contents

Contents

The continuum of care for patients with metastatic colorectal cancer continues to evolve as data from clinical trials evaluating novel agents, treatment combinations or treatment sequencing become available. The concept of continued angiogenesis suppression through multiple lines of therapy has been hypothesized to be beneficial in terms of increas...

Alternative Titles

Full title

Bevacizumab beyond first disease progression in metastatic colorectal cancer: a review of recent clinical trial data

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracacademiconefile_A409374858

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracacademiconefile_A409374858

Other Identifiers

ISSN

1758-194X

E-ISSN

1758-1958

DOI

10.2217/crc.15.1

How to access this item